PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
9.68M
Better than CGTX's estimated revenue of 0.
-1.93M
Worse than CGTX's estimated ebitda of 0.
-1.38
Worse than CGTX's estimated eps of -0.43.
-41.62M
Worse than CGTX's estimated net income of -16.98M.
-1.93M
Worse than CGTX's estimated ebit of 0.
358.54M
Worse than CGTX's estimated sg&a expense of 0.
Analyze DCF forecasts for the company and compare them with competitors.
1.03M
Better than CGTX's revenue of 0.00.
-9.97%
Worse than CGTX's revenue growth rate of 0.00%.
-33.41M
Worse than CGTX's ebitda of -21.13M.
-3243.20%
Worse than CGTX's ebitda margin of 100.00%.
-34.10M
Worse than CGTX's ebit of -21.37M.
-3311.07%
Worse than CGTX's ebit margin of 100.00%.
699.00K
Worse than CGTX's depreciation of 235.00K.
108.91M
Better than CGTX's total cash of 41.56M.
10573.79%
Better than CGTX's cash as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
10.13M
Worse than CGTX's accounts payable of 3.22M.
983.50%
Worse than CGTX's payables as percentage of revenue of 100.00%.
-366.00K
Better than CGTX's capital expenditure of -171.00K.
-35.53%
Better than CGTX's capex as percentage of revenue of 100.00%.
4.99%
Better than CGTX's weighted average cost of capital (wacc) of 8.23%.
5.02%
Better than CGTX's cost of equity of 8.74%.
4.08%
Worse than CGTX's cost of debt of 4.06%.
-0.23
Better than CGTX's beta of 0.99.
30.07M
Better than CGTX's diluted shares outstanding of 39.73M.
1.57M
Worse than CGTX's total debt of 814.00K.
49.31M
Better than CGTX's total equity of 13.11M.
50.89M
Better than CGTX's total capital of 13.92M.
3.09%
Better than CGTX's debt weighting of 5.85%.
96.91%
Better than CGTX's equity weighting of 94.15%.
-32.98M
Worse than CGTX's ebiat of 756.01K.
-28.05M
Worse than CGTX's unlevered free cash flow of 456.01K.
2.00%
Equal to CGTX's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than CGTX's net debt of -24.20M.
71.33M
Better than CGTX's equity value of 24.84M.
2.37
Better than CGTX's equity value per share of 0.63.